Abiraterone is a potent steroidal antiandrogen that functions as a CYP17 inhibitor to block testosterone synthesis, primarily treating metastatic castration-resistant prostate cancer. Pharmaceutical laboratories… Read more
![Chemical structure of ((1aS,1bR,2S,7aS)-1-Bromo-1b,4-dimethoxy-5-methyl-3,6-dioxo-1a,1b,2,3,6,6b,7,7a-octahydro-1H-benzo[4,5]pentaleno[1,2-b]azirin-2-yl)methyl carbamate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1aS1bR2S7aS-1-Bromo-1b4-dimethoxy-5-methyl-36-dioxo-1a1b2366b77a-octahydro-1H-benzo45pentaleno12-bazirin-2-ylmethyl-carbamate.png&w=3840&q=75)
![Chemical structure of (10R,13S)-10,13-Dimethyl-17-(pyridin-3-yl)-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F10R13S-1013-Dimethyl-17-pyridin-3-yl-234789101112131415-dodecahydro-1H-cyclopentaaphenanthren-3-ol.png&w=3840&q=75)
![Chemical structure of (10R,13S)-10,13-Dimethyl-17-(pyridin-3-yl)-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl 4-methylbenzenesulfonate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F10R13S-1013-Dimethyl-17-pyridin-3-yl-234789101112131415-dodecahydro-1H-cyclopentaaphenanthren-3-yl-4-methylbenzenesulfonate.png&w=3840&q=75)
![Chemical structure of (2aS,4S,6aS,6bS,8aS,8bR,9aR,10aS,10bR)-6a,8a-Dimethyl-8b-(pyridin-3-yl)hexadecahydro-1H-naphtho[2',1':4,5]indeno[1,2-b]oxiren-4-yl Acetate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F219843-78-4-2aS4S6aS6bS8aS8bR9aR10aS10bR-6a8a-Dimethyl-8b-pyridin-3-ylhexadecahydro-1H-naphtho2145indeno12-boxiren-4-yl-Acetate.png&w=3840&q=75)
![Chemical structure of (3R,8R,9S,10R,13S,14S)-10,13-Dimethyl-17-(pyridin-3-yl)-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl propionate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F3R8R9S10R13S14S-1013-Dimethyl-17-pyridin-3-yl-234789101112131415-dodecahydro-1H-cyclopentaaphenanthren-3-yl-propionate.png&w=3840&q=75)
![Chemical structure of (3S,10R,13S)-10,13-Dimethyl-17-(trifluoromethylsulfonyloxy)-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1Hcyclopenta[a]phenanthren-3-yl 2,2,2-trifluoroacetate;](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1802323-89-2-3S10R13S-1013-Dimethyl-17-trifluoromethylsulfonyloxy-234789101112131415-dodecahydro-1Hcyclopentaaphenanthren-3-yl-222-trifluoroacetate.png&w=3840&q=75)
![Chemical structure of (3S,3'S,8R,8'R,9S,9'S,10R,10'R,13S,13'S,14S,14'S,17E,17'E)-17,17'-(Hydrazine-1,2-diylidene)bis(10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol)](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1713262-50-0-3S3S8R8R9S9S10R10R13S13S14S14S17E17E-1717-Hydrazine-12-diylidenebis1013-dimethyl-2347891011121314151617-tetradecahydro-1H-cyclopentaaphen.png&w=3840&q=75)
![Chemical structure of (3S,8R,9S,10R,13S,14S)-17-(1-(Hydroxyimino)ethyl)-10,13-dimethyl-7-oxo-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl acetate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F3S8R9S10R13S14S-17-1-Hydroxyiminoethyl-1013-dimethyl-7-oxo-234789101112131415-dodecahydro-1H-cyclopentaaphenanthren-3-yl-acetate.png&w=3840&q=75)
![Chemical structure of (3S,8R,9S,10R,13S,14S)-17-Acetyl-10,13-dimethyl-7-oxo-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl acetate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F19324-55-1-3S8R9S10R13S14S-17-Acetyl-1013-dimethyl-7-oxo-234789101112131415-dodecahydro-1H-cyclopentaaphenanthren-3-yl-acetate.png&w=3840&q=75)
![Chemical structure of (3S,8R,9S,10R,13S,14S)-17-Ethyl-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl acetate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2118-32-3-3S8R9S10R13S14S-17-Ethyl-1013-dimethyl-234789101112131415-dodecahydro-1H-cyclopentaaphenanthren-3-yl-acetate.png&w=3840&q=75)
![Chemical structure of (3S,8R,9S,10S,13S,14S)-10,13-Dimethyl-17-(pyridin-3-yl)-2,3,4,5,6,7,8,9,10,11,12,13,14,15-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1382475-29-7-3S8R9S10S13S14S-1013-Dimethyl-17-pyridin-3-yl-23456789101112131415-tetradecahydro-1H-cyclopentaaphenanthren-3-ol.png&w=3840&q=75)
![Chemical structure of (3S,8S,9S,10R,13S,14S)-10,13-Dimethyl-17-(pyridin-3-yl)-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F3S8S9S10R13S14S-1013-Dimethyl-17-pyridin-3-yl-2347891011121314151617-tetradecahydro-1H-cyclopentaaphenanthren-3-ol.png&w=3840&q=75)
![Chemical structure of (3S,8S,9S,10R,13S,14S,17S)-10,13-Dimethyl-17-(pyridin-3-yl)-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl acetate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F98449-11-7-3S8S9S10R13S14S17S-1013-Dimethyl-17-pyridin-3-yl-2347891011121314151617-tetradecahydro-1H-cyclopentaaphenanthren-3-yl-acetate.png&w=3840&q=75)
![Chemical structure of (3β)-16-[(3β)-3-(Acetyloxy)androsta-5,16-dien-17-yl]-17-(3-pyridinyl)-androsta-5,16-dien-3-ol 3-Acetate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F186826-68-6-3-16-3-3-Acetyloxyandrosta-516-dien-17-yl-17-3-pyridinyl-androsta-516-dien-3-ol-3-Acetate.png&w=3840&q=75)
![Chemical structure of (3β)-16-[(3β)-3-Hydroxyandrosta-5,16-dien-17-yl]-17-(3-pyridinyl)-androsta-5,16-dien-3-ol](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F186826-70-0-3-16-3-3-Hydroxyandrosta-516-dien-17-yl-17-3-pyridinyl-androsta-516-dien-3-ol.png&w=3840&q=75)


![Chemical structure of (8R,9S,10R,13S,14S)-10,13-Dimethyl-17-(pyridin-3-yl)-2,7,8,9,10,11,12,13,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl trifluoromethanesulfonate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2697127-18-5-8R9S10R13S14S-1013-Dimethyl-17-pyridin-3-yl-2789101112131415-decahydro-1H-cyclopentaaphenanthren-3-yl-trifluoromethanesulfonate.png&w=3840&q=75)



![Chemical structure of 2-(((3S,8S,9S,10R,14S)-10,17-Dimethyl-2,3,4,7,8,9,10,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl)oxy)tetrahydro-2H-pyran](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2-3S8S9S10R14S-1017-Dimethyl-234789101112141516-dodecahydro-1H-cyclopentaaphenanthren-3-yloxytetrahydro-2H-pyran.png&w=3840&q=75)


![Chemical structure of 3-((3R,8R,9S,10R,13S,14S)-3-((3S,8R,9S,10R,13S,14S)-2,3,4,5,8,9,10,11,12,13,14,15-Dodecahydro-10,13-dimethyl-17-(pyridin-3-yl)-1H-cyclopenta[a]phenanthren-3-yloxy)-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-10,13-dimethyl-1H-cyclopenta[a]phenanthren-17-yl)pyridine](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F3-3R8R9S10R13S14S-3-3S8R9S10R13S14S-234589101112131415-Dodecahydro-1013-dimethyl-17-pyridin-3-yl-1H-cyclopentaaphenanthren-3-yloxy-234789101112131415-.png&w=3840&q=75)
![Chemical structure of 3-((8S,9S,10R,13S,14S)-10,13-Dimethyl-2,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl)pyridine](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F3-8S9S10R13S14S-1013-Dimethyl-27891011121314151617-dodecahydro-1H-cyclopentaaphenanthren-17-ylpyridine.png&w=3840&q=75)





![Chemical structure of 4-(((3S,8R,9S,10R,13S,14S)-10,13-Dimethyl-17-(pyridin-3-yl)-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl)oxy)-4-oxobutanoic acid](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1629778-77-3-4-3S8R9S10R13S14S-1013-Dimethyl-17-pyridin-3-yl-234789101112131415-dodecahydro-1H-cyclopentaaphenanthren-3-yloxy-4-oxobutanoic-acid.png&w=3840&q=75)


















Abiraterone is a potent steroidal antiandrogen that functions as a CYP17 inhibitor to block testosterone synthesis, primarily treating metastatic castration-resistant prostate cancer. Pharmaceutical laboratories utilize this category of reference standards, which includes the active pharmaceutical ingredient, its acetate prodrug, and various metabolites, to conduct rigorous quality control and analytical testing. These compounds are essential for accurate impurity profiling, allowing researchers to identify and quantify degradation products formed through pathways such as hydrolysis and oxidation during synthesis or storage. Furthermore, the inclusion of stable isotope labelled compounds enables precise quantitative analysis in complex biological matrices during method validation and stability studies. By providing these highly characterized reference materials, the catalogue supports the development of robust analytical procedures necessary to ensure therapeutic efficacy and maintain regulatory compliance throughout the drug development lifecycle.